Orthopedic Cartilage Repair Market Size, Share, and Trends Analysis | Global | 2025-2031 | MedCore | Includes: Osteochondral Allograft Market, Meniscal Allograft Market, and 2 more
세계의 정형외과 연골 수복 시장 규모는 2024년에 4억 500만 달러에 달했습니다. 이 시장은 9.2%의 CAGR로 확대하며, 2031년에는 7억 5,000만 달러에 달할 것으로 예측됩니다.
민간 보험에 가입한 환자들에게도 고가의 치료비는 여전히 큰 장벽으로 작용하고 있습니다. 이 비용은 예측 기간 중에도 크게 낮아지지 않을 것으로 예상되며, 이는 판매량 증가에 걸림돌이 될 것으로 보입니다.
2024년 FDA가 연골 복구를 위한 관절경 전달 방법을 승인하면 최소침습 수술과 회복 시간 단축이 촉진됩니다.
세계의 정형외과 연골 수복 시장에 대해 조사했으며, 시장의 개요와 시장 분석과 예측, 촉진요인과 억제요인, 경쟁 구도 등을 제공하고 있습니다.
목차
개요
- 세계의 정형외과 연골 수복 시장 개요
- 대상 지역
서론
시술 건수
- 정형외과적 연골 수복 수술
- 골연골 이식 수술
- 반월판 동종 이식 수술
- 자가 연골 세포 이식 수술
- 골연골 자가 이식 수술
시장 개요
시장 분석과 예측
- 정형외과 연골 수복 시장 전체
- 골연골 이식 시장
- 반월판 동종 이식 시장
- 자가 연골 세포 이식 시장
- 골연골 이식 시장
촉진요인과 억제요인
경쟁 시장 점유율 분석
KSA
The global orthopedic cartilage repair market was valued at $405 million in 2024 and is expected to grow at a CAGR of 9.2%, reaching $750 million by 2031.
This market includes four key product categories:
- Osteochondral Allografts
- Meniscal Allografts
- Autologous Chondrocyte Implantation (ACI)
- Osteochondral Autografts
Market Insights & Data Coverage
- Unit Sales & Average Selling Prices
- Market Size & Growth Trends
- Procedure Numbers
- Market Drivers & Limiters
- Market Forecasts Until 2031
- Historical Data (2021-2023)
- Competitive Landscape, Mergers & Acquisitions
- Company Profiles & Product Portfolios
Market Trends & Challenges
- High Cost as a Key Market Limiter
* The high cost of procedures remains a significant barrier for patients, even for those with private insurance.
* This cost is not expected to decline significantly over the forecast period, limiting unit sales.
- Technological Advancements Driving Growth
* The FDA's approval of arthroscopic delivery methods for cartilage repair in 2024 enhances minimally invasive procedures and faster recovery times.
Market Share Insights
Top Competitors in the Global Orthopedic Cartilage Repair Market (2024):
1 Vericel - Market Leader
* Offers MACI(R), an autologous cartilage repair therapy for knee defects.
* The FDA-approved arthroscopic delivery method (August 2024) enables less invasive procedures.
2 Octane Medical Group - Second-Largest Competitor
* Expanded its portfolio by acquiring B. Braun's global orthobiologics business (TETEC AG, Aesculap Biologics).
* Offers NOVOCART(R) 3D (matrix-associated ACI system) and NOVOCART(R) Inject (injectable hydrogel-based cartilage repair).
3 Arthrex - Third-Largest Competitor
* Provides Allograft OATS(R), Autograft OATS(R), BioCartilage(R), and Cartiform(R) for osteochondral defect repair.
* The PowerPick system enables microdrilling for microfracture procedures.
Market Segmentation Summary
- Osteochondral Allograft Market
- Meniscal Allograft Market
- Autologous Chondrocyte Implantation (ACI) Market
- Osteochondral Autograft Market
Global Research Scope
* North America (U.S., Canada)
* Latin America (Brazil, Mexico, Argentina, Colombia, Chile)
* Western Europe (Germany, France, U.K., Spain, Italy)
* Central & Eastern Europe (Poland, Russia, Turkey, Hungary)
* Middle East (Saudi Arabia, UAE, Israel)
* Asia Pacific (China, Japan, India, South Korea, Australia)
* Africa (South Africa, Egypt, Nigeria, Kenya)
- Base Year: 2024
- Forecast Period: 2025-2031
- Historical Data: 2021-2023
Quantitative Coverage
- Market Size, Market Shares
- Market Forecasts, Growth Rates
- Units Sold, Average Selling Prices
- Procedure Numbers
Qualitative Coverage
- COVID-19 Impact
- Market Growth Trends & Limiters
- Competitive Analysis & SWOT for Top Competitors
- Mergers & Acquisitions
- Company Profiles & Product Portfolios
- FDA Recalls, Disruptive Technologies
- Disease Overviews
Data Sources:
- Primary Interviews with Industry Leaders
- Government Physician Data & Regulatory Data
- Hospital Private Data
- Import & Export Data
- iData Research Internal Database
TABLE OF CONTENT
- 8.1 Executive Summary
- 8.1.1 Global Orthopedic Cartilage Repair Market Overview
- 8.1.2 Regions Included
- 8.2 Introduction
- 8.2.1 Anatomy
- 8.2.2 Methods for Cartilage Repair
- 8.2.2.1 Osteochondral Allograft Transfer
- 8.2.2.2 Autologous Chondrocyte Implantation
- 8.2.2.3 Meniscal Allograft Transplantation
- 8.2.2.4 Osteochondral Autograft
- 8.2.2.5 Microfracture
- 8.2.2.6 Microfracture Adjunct
- 8.2.2.7 Osteoarticular Autograft Transfer System
- 8.2.2.8 Particulated Juvenile Allograft
- 8.3 Procedure Numbers
- 8.3.1 Total Orthopedic Cartilage Repair Procedures
- 8.3.2 Osteochondral Allograft Procedures
- 8.3.3 Meniscal Allograft Procedures
- 8.3.4 Autologous Chondrocyte Implantation Procedures
- 8.3.5 Osteochondral Autograft Procedures
- 8.4 Market Overview
- 8.4.1 By Segment
- 8.4.2 By Region
- 8.5 Market Analysis and Forecast
- 8.5.1 Total Orthopedic Cartilage Repair Market
- 8.5.2 Osteochondral Allograft Market
- 8.5.3 Meniscal Allograft Market
- 8.5.4 Autologous Chondrocyte Implantation Market
- 8.5.5 Osteochondral Autograft Market
- 8.6 Drivers and Limiters
- 8.6.1 Market Drivers
- 8.6.2 Market Limiters
- 8.7 Competitive Market Share Analysis
